Inve US ▾

Amphenol (APH) earnings

AMPHENOL CORP /DE/· Information Technology

Results to
Jun 2026
Latest analysed call
Jun 2026 (Q2 FY26)
Balance sheet to
Dec 2025

Company research is public. Sign in to keep your own companies, notes and cases.

Amphenol earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue8,758 $ million+55.0% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin29.5 %+4.4 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit1,769 $ million+62.1% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.

Source: Inve data from filed results (SEC filings) · to Jun 2026

Guidance

What management said, and what became of it

71 of 76 judged targets kept · 34 open · verdicts reflect calls analysed to Jun 2026.

AMPHENOL CORP /DE/ management guidance track record: 110 targets tracked across analysed earnings calls (71 achieved, 5 missed, 34 open).

TargetOriginal wordingSaidLatest callVerdict
Adjusted diluted EPS$1.14 to $1.16Mar 2026Jun 2026:On an adjusted basis, diluted EPS was a record $1.35 and increased by 67% compared to $0.81 in the second quarter of 2025.
Call transcript, Jun 2026 · no direct link
Achieved
CommScope acquisition accretion to adjusted EPS$0.15Dec 2025Jun 2026:Indeed, we now expect CommScope to deliver $4.6 billion of sales and $0.30 of accretion for the full year 2026. And this represents a significant upgrade from our previous expectations of $4.1 billion and $0.15.
Call transcript, Jun 2026 · no direct link
Revised Up
Adjusted diluted EPS$1.40 to $1.42Jun 2026Jun 2026:and adjusted diluted EPS in the range of $1.40 to $1.42.
Call transcript, Jun 2026 · no direct link
New

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

5 of AMPHENOL CORP /DE/'s 110 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 107 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. US Pro opens 100 a month: first month free, no card.
See the full record

Price

$80.28 +1.17% · +$0.93

Last close Oct 19, 2026 · US · USD

Performance −36.1% 1Y

$80$100$120$140$160$180Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Aug 26Oct 26Sep 2025 (Q3 FY25) — 22 Oct 2025Dec 2025 (Q4 FY25) — 28 Jan 2026Mar 2026 (Q1 FY26) — 29 Apr 2026Jun 2026 (Q2 FY26) — 29 Jul 2026

1Y: $125.65 on 17 Oct 2025 → $80.28. High $176.32 (30 Jun 2026), low $77.26 (16 Sept 2026).

Previous close
$79.35
52-week range
$77.26 – $176.32
One year
−37.12%

Overview

Symbol
APH
Exchange
US
Currency
USD

Your own record

Start an Inve Case for AMPHENOL CORP /DE/

Free account. Everything above stays public.

Write why you follow AMPHENOL CORP /DE/ and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds